Du Jia, Liu Hao, Xu Jing, Lu Chun-Mei, Zhou Jin-Feng, Wu Ping-Hua, Zheng Li-Yuan, Li Xin-Wei
Department of Acupuncture-Moxibustion and Tuina, Zhejiang Provincial Tongde Hospital, Hangzhou 310012, China.
Zhejiang Provincial Tiantai County Hospital of TCM.
Zhongguo Zhen Jiu. 2020 May 12;40(5):493-7. doi: 10.13703/j.0255-2930.20190507-k0004.
To verify the clinical effect of acupoint embedding therapy on post-stroke constipation.
The multi-central randomized controlled trial was adopted. 210 patients of post-stroke constipation were divided into an acupoint embedding group (105 cases, 4 cases dropped off) and a sham-embedding group (105 cases, 6 cases dropped off). In the acupoint embedding group, the acupoint embedding therapy was used at Tianshu (ST 25), Daheng (SP 15), Xiawan (CV 10), Zhongwan (CV 12), Qihai (CV 6), Guanyuan (CV 4) and Daju (ST 27). In the sham-embedding group, the sham-embedding therapy was given, in which, the acupoint selection, needle devices and manipulation were the same as the acupoint embedding group. But, no absorbable surgical suture was used in the needle tube. The treatment was given once every two weeks and 4 treatments were required in either group. It was to compare the weekly average complete spontaneous bowel movements (CSBMs) during treatment (from the 3rd to the 8th week) between the two groups, the weekly average spontaneous bowel movements (SBMs), Bristol stool form score (BSFS), the score of the patient assessment of constipation quality of life questionnaire (PAC-QOL) and the score of defecation difficulty before and after treatment.
The percentage of the cases with weekly average CSBMs ≥ 3 times in the patients of the acupoint embedding group was higher markedly than the sham-embedding group [91.1% (92/101) vs 43.4% (43/99), <0.01]. Compared with the values before treatment, the weekly average SBMs and BSFS scores after treatment were all increased obviously in the two groups (<0.01), and PAC-QOL score and the score of defecation difficulty were reduced remarkably (<0.01). After treatment, the increase range of SBMs and BSFS scores, as well as the decrease range of PAC-QOL score and the defecation difficulty score in the acupoint embedding group were all higher than the sham-embedding group respectively (<0.05).
The acupoint embedding therapy remarkably increases the spontaneous bowel movements, improves in feces form and defecation difficulty and strengthens the quality of life in the patients of post-stroke constipation.
验证穴位埋线疗法对脑卒中后便秘的临床疗效。
采用多中心随机对照试验。将210例脑卒中后便秘患者分为穴位埋线组（105例，脱落4例）和假埋线组（105例，脱落6例）。穴位埋线组采用穴位埋线疗法，选取天枢（ST25）、大横（SP15）、下脘（CV10）、中脘（CV12）、气海（CV6）、关元（CV4）、大巨（ST27）等穴位。假埋线组采用假埋线疗法，其选穴、针具及操作方法与穴位埋线组相同，但针管内不使用可吸收外科缝线。两组均每两周治疗1次，各治疗4次。比较两组治疗期间（第3至8周）每周平均完全自主排便次数（CSBMs）、每周平均自主排便次数（SBMs）、布里斯托大便性状评分（BSFS）、便秘患者生活质量问卷（PAC-QOL）评分及治疗前后排便困难评分。
穴位埋线组患者每周平均CSBMs≥3次的病例百分比显著高于假埋线组[91.1%（92/101）对43.4%（43/99），<0.01]。与治疗前相比，两组治疗后每周平均SBMs及BSFS评分均明显升高（<0.01），PAC-QOL评分及排便困难评分均明显降低（<0.01）。治疗后，穴位埋线组SBMs及BSFS评分的升高幅度，以及PAC-QOL评分及排便困难评分的降低幅度均分别高于假埋线组（<于0.05）。
穴位埋线疗法可显著增加脑卒中后便秘患者的自主排便次数，改善粪便性状及排便困难情况，提高患者生活质量。
